Canadian Bioceutical Subsidiary Signs Collaboration Agreement With A Leading Israeli Medical Cannabis Research Company – Yahoo Finance

Its product portfolio includes standardized oils, creams, suppositories and capsules, both THC and CBD based. The products are manufactured at various degrees of potency in order to meet the specific needs, ages, and medical conditions of the various patients. Many other unique cannabis formulations are currently under development. Each of Cannabliss’ medicinals undergoes rigorous testing and is supplied to authorized patients holding Ministry of Health permits. Prof. Reuven Or is the Head of the Medical Consultancy Department at the company and is also the Director of the Bone Marrow Transplant Department at Hadassah Ein Karem Hospital.
For the original version including any supplementary images or video, visit

Comments are closed.